TXMD (TherapeuticsMD, Inc.) קצב צמיחת רווח למניה בשנה הנוכחית

סמלים רשמיים של חברת TherapeuticsMD, Inc. (TXMD)

TherapeuticsMD, Inc. (TXMD) focuses on an ethical approach to women's health while developing human capital. Management has pivoted its strategy toward monetizing proprietary rights through licensing. Current revenues are based on royalties with zero debt. The 12-month earnings per share growth rate, as illustrated by this chart on GURU.Markets, confirms this trend, where 0.00 represents the latest level value.

TXMD - צמיחת רווח נקי למניה השנה therapeuticsmd.com בטווח 04.07.2022 - 16.11.2026

פילוחי מדדים פיננסיים ומדדי שוק עבור therapeuticsmd.com (TXMD)

- מדדי הערכת שווי שוק של העסק:
ניתוח בסיסי של החברה:TherapeuticsMD, Inc. (TXMD)
מוצרים מיוצרים של TherapeuticsMD, Inc.

This metric measures the annual change in earnings per share, determining the actual efficiency of net income generation. A positive trend signals growth in capitalization, while a decline indicates the erosion of fundamental value. Analyzing relative EPS YoY dynamics allows for the identification of hidden imbalances between market price and actual results. For TherapeuticsMD, Inc. (TXMD), this indicator reflects the monetization of patent protection under strict FDA oversight. Thus, this chart confirms the business resilience of the company within the women's health market.